Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Dysregulation During Sepsis: A Natural History Cohort

NCT07735741 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT07735741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07735741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Dysregulation During Sepsis: A Natural History Cohort
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Observational
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
January 31, 2037
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, sepsis-associated immune dysregulation, septic shock